Thermo Fisher Scientific Strengthens Bioprocessing Capabilities with New Products at INTERPHEX 2016
OREANDA-NEWS. April 27, 2016. Thermo Fisher Scientific, the world leader in serving science, will highlight its bioprocessing production capabilities “built for biopharma,” at the International Pharmaceutical Expo (INTERPHEX) to support its expanding customer base of global biopharmaceutical manufacturers. New products at the show include innovations in single-use technologies, cell culture, protein purification and mass spectrometry. Experts will be on hand to provide detailed information to help biopharma producers accelerate innovation and enhance productivity. Visit booth 3544 in the Jacob Javits Center from April 27-29, 2016.
“Emerging markets for precision medicine, continued growth for biotherapeutics and a renewed focus on cost, increase pressure on customers to identify efficiencies in their production processes,” said Cory Stevenson, president of Thermo Fisher’s bioproduction business. “Our emphasis on best-in-class products across the workflow helps our customers to accelerate innovation and increase productivity.”
Innovations in Analytical Technologies
Thermo Fisher has
developed a comprehensive protein analytics platform to support
microbial and process quality when accuracy and time-to-results are
critical. The Applied
Biosystems ProteinSEQ Protein Quantitation System, a breakthrough
immuno-PCR platform for residual host-cell protein (HCP) and protein A
quantitation, is designed for sensitive and robust protein quantitation
with dynamic range, providing four orders of magnitude of greater
confidence and quality of data throughout the production process.
Glycosylation is one of the key critical quality attributes of monoclonal antibody-based biotherapeutics, affecting a biological drug’s safety, efficacy, clearance and immunogenicity. The new Applied Biosystems GlycanAssure Glycan Analysis and Quantitation System is the first solution to combine high-throughput and high-data quality in an integrated platform. This helps save labor, time and analysis cost by using a simple sample preparation, a multi-capillary CE instrument and assay-specific software.
Introducing Precision into the Bioprocessing Workflow
To
enhance productivity while improving protein quality, Thermo Fisher
introduced Gibco
GlycanTune, a feeding supplement engineered to provide precision and
control in predictively shifting glycan profiles. Based on EfficientFeed
technology, the feed also enables a multi-fold increase in titers
and maximizes bioreactor utilization.
Thermo Fisher’s single-use technologies comprise best-in-class bioreactors, mixers, fermentors and ancillary products that enable efficiency, speed and reproducible results. At the core are both standard and custom-built BioProcess Containers, which are specially engineered films configured to fit customers’ unique applications and provide process flexibility.
Overcoming Technical and Economic Challenges in the Purification
Process
To address downstream purification challenges, new
Thermo Scientific POROS
CaptureSelect AAV8 and POROS
CaptureSelect AAV9 Affinity Resins are engineered to address the
high selectivity and capacity requirements needed for the purification
of adeno-associated virus types 8 and 9, which are often used for gene
therapy applications.
Also featured at INTERPHEX is a novel approach to protein A capture chromatography. Thermo Scientific POROS MabCapture A Select Resin combines high-throughput purification performance at a lower price to reduce the cost of pre-clinical development and process-scale manufacturing.
Increasing Confidence in Biotherapeutic Characterization
Finally,
regulatory changes and increased competition from biosimilar products
continue to pressure biotherapeutic drug manufacturers to streamline
their analytical processes. The recently launched Thermo
Scientific Vanquish Flex system is a UHPLC instrument with a fully
biocompatible flow path, sample pre-compression and a broad range of
detectors to suit biotherapeutic analysis from intact proteins to
unlabeled free glycans.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc.
is the world leader in serving science, with revenues of \\$17 billion and
more than 50,000 employees in 50 countries. Our mission is to enable our
customers to make the world healthier, cleaner and safer. We help our
customers accelerate life sciences research, solve complex analytical
challenges, improve patient diagnostics and increase laboratory
productivity. Through our premier brands – Thermo Scientific, Applied
Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we
offer an unmatched combination of innovative technologies, purchasing
convenience and comprehensive support. For more information, please
visit www.thermofisher.com
Комментарии